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Abstract
Purpose In ASPECTS, 10 brain regions are scored visually for presence of acute ischemic stroke damage. We evaluated
automated ASPECTS in comparison to expert readers.
Methods Consecutive, baseline non-contrast CT-scans (5-mm slice thickness) from the prospective MR CLEAN trial (n = 459,
MR CLEAN Netherlands Trial Registry number: NTR1804) were evaluated. A two-observer consensus for ASPECTS regions
(normal/abnormal) was used as reference standard for training and testing (0.2/0.8 division). Two other observers provided
individual ASPECTS-region scores. The Automated ASPECTS software was applied. A region score specificity of ≥ 90% was
used to determine the software threshold for detection of an affected region based on relative density difference between affected
and contralateral region. Sensitivity, specificity, and receiver-operating characteristic curves were calculated. Additionally, we
assessed intraclass correlation coefficients (ICCs) for automated ASPECTS and observers in comparison to the reference
standard in the test set.
Results In the training set (n = 104), with software thresholds for a specificity of ≥ 90%, we found a sensitivity of 33–49% and an
area under the curve (AUC) of 0.741–0.785 for detection of an affected ASPECTS region. In the test set (n = 355), the results for
the found software thresholds were 89–89% (specificity), 41–57% (sensitivity), and 0.750–0.795 (AUC). Comparison of auto-
mated ASPECTS with the reference standard resulted in an ICC of 0.526. Comparison of observers with the reference standard
resulted in an ICC of 0.383–0.464.
Conclusion The performance of automated ASPECTS is comparable to expert readers and could support readers in the detection
of early ischemic changes.
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Introduction
In the treatment of acute ischemic stroke, the severity and
extent of an ischemic stroke lesion could be used as one of
the parameters to select eligible patients for endovascular
treatment [1].[1] NCCT of the brain is the most widely used
modality for assessment of early focal signs of ischemic dam-
age in stroke patients. To quantify the extent of ischemia on
NCCT, the Alberta Stroke Program Early Computed
Tomography Score (ASPECTS) has been introduced. In
ASPECTS, 10 brain regions are dichotomously scored on
the presence of early ischemic stroke signs, resulting in a
range of 0 to 10, with 1 point subtracted for any evidence of
early ischemic change in each defined region on the CT scan
[2]. ASPECTS scoring requires a high level of expertise to
detect subtle changes on NCCT in the early phase of brain
ischemia [3]. This expertise is not available in every center
where stroke patients are presented. Consequently, there is
considerable interrater variability [4–7]. Automated tools have
been developed to counter these challenges [3, 8–11].
Siemens has developed a fully automated post-processing
tool to score ASPECTS on NCCT [12, 13]. The performance
of automated software in comparison to physicians should be
tested before this software is used in clinical practice as aid for
physicians. In this study, we evaluated Frontier ASPECTS soft-
ware for the detection of early ischemic brain changes on
NCCT scans acquired on a broad range of different CT
scanners.
Materials and methods
Study design
We used image data from the Multicenter Randomized
Clinical Trial of Endovascular Treatment for Acute Ischemic
Stroke in The Netherlands (MR CLEAN, MR CLEAN
Netherlands Trial Registry number NTR1804. Current
Controlled Trials number, ISRCTN10888758), a prospective,
consecutive study which was performed in 16 stroke centers
in the Netherlands [14]. Detailed study methods and eligibility
criteria were published previously [15].
Patients with an occlusion of the intracranial carotid artery,
the M1/M2 segment of the middle cerebral artery or the A1/A2
segment of the anterior cerebral artery were included in the MR
CLEAN trial (n = 500). ASPECTS or the severity and the extent
of early ischemic changes were not used as exclusion criteria.
The MR CLEAN study protocol was approved by the cen-
tral medical ethics committee of the Erasmus MC and the
research board of each participating center. All patients or
their legal representatives provided written informed consent
before randomization.
Imaging data and evaluation
As MR CLEAN was a multicenter trial, various CT scanner
models had been used to obtain the NCCT of the brain which
resulted in a heterogeneous dataset with scans from all major
CT scanner manufacturers (GE Healthcare, Chicago, USA;
Philips Healthcare, Amsterdam, The Netherlands; Siemens
Healthineers, Erlangen, Germany; Toshiba, Tokyo, Japan).
All patients with NCCT images with 5-mm slice thickness
were included in the current study.
All baseline NCCT scans were evaluated for ASPECTS
four times by expert readers who were unaware of the treat-
ment group assignments and final outcome. The expert
readers were blinded for all clinical information, except the
clinically affected cerebral hemisphere.
To define a reference standard for ASPECTS, every CT
scan was first rated by two expert readers from a pool of eight
readers to produce a consensus score for every ASPECTS
region (n = 10). In case of disagreement, a consensus score
was provided by a third reader [16].
In addition, every CT-scan was rated by two expert readers
from a second pool of nine readers to produce two individual
ASPECTS, hereafter named as ASPECTS of observer 1 and
observer 2, respectively [17].
Frontier ASPECTS
The syngo.via Frontier ASPECTS prototype software (ver-
sion 2.0.1, Siemens Healthcare GmbH, Erlangen, Germany)
allows analyzing NCCT scans for early ischemic changes in
acute stroke in the territory of the middle cerebral arteries. A
probabilistic atlas has been created based on 150 normal
NCCT datasets in which ASPECTS regions (caudate nucleus
(CN), internal capsule (IC), insula (INS), lentiform nucleus
(LN), and 6 regions in the vascular territory of the middle
cerebral artery (M1–M6)) were segmented. This human brain
atlas consists of ten volumes of interest for each brain hemi-
sphere which represent the 10 ASPECTS regions. After auto-
matically fitting of the atlas to an NCCT brain, likelihood for
belonging to a specific ASPECTS region is appointed to every
voxel. The likelihood of every voxel translates to the
weight of the voxel-specific HU for computing the mean
HU of every ASPECTS region. To exclude cerebrospinal
fluid, old infarcts, bone and calcifications, and voxels that
are either too dark (below 10 HU) or too bright (above 55
HU) are excluded.
The relative difference in mean HU between the individual
ASPECTS region in the affected hemisphere and the contra-
lateral hemisphere is computed and presented as a percentage
HU difference. By using a predefined threshold for the relative
HU difference, each ASPECTS region in the affected hemi-
sphere is classified as affected (ischemic changes detected by
the software) or not affected. The number of affected regions
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is used to calculate an ASPECT score. ASPECTS region–
specific threshold values are used for the classification into
ischemic and non-ischemic ASPECTS regions. The default
threshold values were based on initial evaluations in patients
in which the automated ASPECTS was optimized with CT
perfusion–based infarct core assessment as reference standard
[18]. The affected cerebral hemisphere is selected automati-
cally by the software. If needed, the automated assessed af-
fected hemisphere side can be adjusted to match the clinically
affected cerebral hemisphere.
Statistical analysis
To define the optimal threshold values for the relative HU
change in the ASPECTS regions and to validate the find-
ings, the included patients were divided in a training set
(proportion of whole dataset 0.2) and a test set (proportion
of whole dataset 0.8) using stratified random sampling.
The datasets were stratified for affected ASPECTS regions
(CN, IC, INS, LN, M1–M6) and for CT-scanner manufac-
turer. The training set and test set were assessed for signif-
icant differences in age, sex, NIHSS at baseline, stroke
side, ischemic stroke history, prestroke modified Rankin
Scale, and reference standard ASPECTS using t tests and
chi-squared tests.
A specificity of ≥ 90% was used in the training set to
find the software threshold settings with the optimal corre-
lation between the computed ASPECTS and the reference
standard to detect ischemic changes (Online Resource).
Receiver-operating characteristic curves were created to
calculate the area under the curve and to assess the sensi-
tivity and specificity of the computed ASPECTS to detect
ischemic changes in the test set with the thresholds defined
in the training set. Bland-Altman plots were created to
evaluate for systematic differences between software and
reference standard.
The performance of computed ASPECTS and individual
observers (1 and 2) in comparison to the reference standard as
well as interobserver agreement was assessed with the
intraclass correlation coefficient (ICC) using a one-way ran-
dom-effects, absolute agreement, single-rater/measurement
model (ICC[1,1]). The strictest ICC model was used because
a selection of readers out of a panel of multiple expert readers
assessed the ASPECTS [19]. For the ICC, values less than 0.5
are indicative of poor reliability, values between 0.5 and 0.75
indicate moderate reliability, values between 0.75 and 0.9 in-
dicate good reliability, and values greater than 0.90 indicate
excellent reliability. In addition, agreement per region (normal
and abnormal) and agreement for trichotomized ASPECTS
(0–4, 5–7, 8–10) were reported. All analyses were performed
with the use of the SPSS software package, version 24.0.0.1
and R, version 3.5.1.
Results
Patients
From theMRCLEAN trial, 463 patients had a baseline NCCT
with a 5-mm slice thickness. The NCCTs of 4 patients could
not be processed by the automated software due to reading
errors, leaving 459 (> 99%) patients available for analysis
(Fig. 1). For those 459 patients, 18 different scanners from 4
different manufacturers were used for NCCT acquisition
(Online Resource, Table 1).
The affected cerebral hemisphere in Frontier ASPECTS
matched the clinically affected hemisphere in 86% of the pa-
tients. The remaining scans (65) were adjusted to match the
clinically affected brain hemisphere. Twenty-four of the 65
wrong classifications (37%) had an ASPECTS of 7–8, and
36 (55%) had an ASPECTS of 9–10 (Online Resource,
Table 2). However, after correcting for the affected hemi-
sphere on imaging, the discriminating performance did not
improve significantly (Online Resource, Figure 2; Online
Resource, Table 4). Stratified random sampling resulted in
allocation of 104 patients (23%) to the training set and alloca-
tion of 355 patients (77%) to the test set. Due to stratification
limitations, this division was not exactly a 20%/80% division.
No significant differences were found between the training set
and test set (Table 1).
Training set
In the training set (n = 104), with software thresholds for a
specificity of ≥ 90%, we found a sensitivity of 33–49% and an
area under the curve (AUC) of 0.741–0.785 for detection of an
affected ASPECTS region (Online Resource, table 4).
Validation with test set
The area under the curve in the test set for assessment of
ischemic changes in the central regions (caudate, insular rib-
bon, internal capsule, and lentiform nucleus) and the cortical
regions (M1–M6) was similar to the area under the curve in
the training set (Table 2). With the optimal threshold value
from the training set for detection of ischemic changes in the
central regions (5.6%), a specificity and sensitivity of 89%
and 57%were found in the test set. With the optimal threshold
value from the training set for detection of ischemic changes
in the cortical regions (4.7%), a specificity and sensitivity of
89% and 41% were found in the test set (Table 2). Overall
computed ASPECTS and reference standard agreed on region
normality in 2276 regions and on the presence of ischemia in
507 regions which resulted in an overall accuracy of 78%. The
accuracy of trichotomized computed ASPECTS was 60%.
The ICC for the full range of ASPECTS was 0.526 (0.447–
0.597). Similar results were obtained with 1 threshold for all
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ASPECTS regions. The Bland-Altman plot for ASPECTS
difference between automated ASPECTS and reference stan-
dard showed a mean difference of 0.59 (95% CI − 3.20–4.39)
(Online Resource, table 5 and figure 2). The default region–
specific thresholds resulted in a lower ICC than the optimized
thresholds.
No differences were found in area under the curve in eval-
uating ASPECTS regions in scans from different vendors
(Online Resource, Table 3).
Comparison of computed ASPECTS to observers
ASPECTS
The agreement per region of computed ASPECTS with the
reference standard was similar to the region agreement of the
observers with the reference standard (78% and 79% versus
84% and 77%). The agreement for trichotomized ASPECTS
for the computed ASPECTS and the observers was 60% and
59% versus 60% and 57% (Table 3).
Comparison of the agreement of computed ASPECTSwith
the reference standard showed an ICC of 0.526 (95% CI
0.447–0.597) with two optimized thresholds for [CN/IC/
INS/LN] and [M1–M6 regions] and an ICC 0.537 (95% CI
0.459–0.607) with one optimized threshold for all 10 regions.
Comparison of the agreement of observers with the reference
standard showed lower ICCs of 0.464 (95% CI 0.378–0.542)
and 0.383 (95% CI 0.291–0.468).
Table 1 Patient characteristics in
the training set and test set Characteristics Training set (n =
104)
Test set (n =
355)
Age - Median (Interquartile range) 64.5 (54.3–77.0) 66 (54.0–76.0)
Male sex no. (%) 62 (59.6) 204 (57.5)
NIHSSa score Median (interquartile range) 17 (13–21) 18 (15–22)
Location of stroke in left hemisphere - no. (%) 52 (50.0) 190 (53.5)
History of ischemic stroke - no. (%) 8 (7.7) 37 (10.4)
Prestroke modified Rankin scale score - no. (%)
0 83 (79.8) 288 (81.1)
1 9 (8.7) 37 (10.4)
2 7 (6.7) 17 (4.5)
> 2 5 (4.8) 14 (3.9)
Duration (minutes) from stroke onset to imaging – Median
(Interquartile range)
109 (65–201) 114 (68–196)
Reference standard ASPECTS
Median (interquartile range) 8 (7–9) 7 (6–9)
0 (%) 1 (1) 1 (0)
1 (%) 0 (0) 3 (1)
2 (%) 0 (0) 3 (1)
3 (%) 1 (1) 10 (3)
4 (%) 3 (3) 18 (5)
5 (%) 6 (6) 37 (10)
6 (%) 13 (13) 36 (10)
7 (%) 25 (24) 72 (20)
8 (%) 25 (24) 80 (23)
9 (%) 16 (15) 52 (15)
10 (%) 14 (14) 43 (12)
a National Institutes of Health Stroke Scale
n = 463
baseline 
5 mm NCCT brain scan
n = 459
n = 104 (23%)
training set
n = 355 (77%)
test set
n = 4 
Could not be processed by 
Frontier ASPECTS due to 
reading errors
Fig. 1. Flow chart of patients included in analysis
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The agreement between observers (overall agreement 86%
and ICC 0.667 (95% CI 0.605–0.721)) was higher than the
agreement between computed ASPECTS and the reference
standard (Table 3).
Discussion
In this study, we evaluated the performance of Frontier
ASPECTS software for the detection of early ischemic brain
changes onNCCT scans. Our study showed a moderate agree-
ment between Frontier ASPECTS and the reference standard,
defined as the consensus between two expert readers. The
agreement was similar to the agreement between individual
readers and the reference standard, but less than interobserver
agreement. Frontiers ASPECTS could aid in visual evaluation
of the NCCT for the detection and quantification of early
ischemic changes due to acute ischemic stroke.
The Frontier ASPECTS software has specific advan-
tages. The exclusion of bone and old infarcts before
assessing the mean density of the ASPECTS regions im-
proves the accuracy of the brain parenchyma density mea-
surements. Old brain infarcts were found in approximately
20% of the NCCT scans and should not be used in the
assessment of ASPECTS. The calculation of the mean
density of the regions and the relative change in density
enables adaption of the threshold to optimize the tool for
specific contexts and allows the future use of the relative
density values instead of the dichotomous outcomes (nor-
mal/abnormal) in prediction models. Machine learning
model algorithms trained on dichotomous outcome will
lack this opportunity [3, 20, 21]. Current disadvantages
are the reading errors in a minority of scans and the mis-
match in the assessment of the affected hemisphere.
However, the latter can be corrected manually, which will
result in a correct assessment of the ASPECTS. Although
recent evidence showed a considerably lower performance
of Frontier ASPECTS, this difference could be explained
by our threshold optimization and the use of software
version 2.0.1 instead of 1.2.0. [12].
A major problem in evaluation of automated software
to support clinical validation is the choice of reference
standard. Previous studies have used as reference standard
the DWI performed within a specified time frame of the
NCCT [3, 20, 21], follow up NCCT [22, 23], or MRI
[24]. In studies in which follow-up NCCT was used as
reference, only lesions that were present on base line and
follow-up imaging were scored [22], or the definite final
infarct core on follow-up NCCT was scored [23]. DWI-
ASPECTS as reference standard could be problematic due
to the potential time delay between test and reference
standard of up to 2 h which could affect the results.
More important are the differences in the underlying sig-
nal changes. The NCCT scan in the early phase could be
completely normal when cytotoxic edema has resulted in
an abnormal DWI signal. The NCCT scan will only reveal
density decrease in the next phase of vasogenic edema.
This might result in low sensitivity of the algorithm in the
early phase after the event. Follow-up imaging as refer-
ence standard ignores the effects of intravenous thrombol-
ysis and endovascular thrombectomy. Minor changes on
NCCT could be reversible after treatment which could
result in a low specificity of the algorithm [23].
Comparing ASPECTS with perfusion changes could
produce valuable information, but it would require a dif-
ferent approach, as abnormalities in perfusion maps,
which are apparent immediately after stroke onset, do
not necessarily lead to imaging abnormalities on NCCT.
However, given the relevance of ASPECTS scoring for
ischemic stroke treatment and the issues with human
ASPECTS scoring like moderate observer agreement,
the purpose of this manuscript is to assess whether soft-
ware can be used to reliably automate the ASPECTS scor-
ing and support clinicians in assessing early ischemic
changes. Therefore, comparing with DWI or perfusion
imaging is beyond the aim of this paper.
We therefore used consensus readings of expert observers as
reference standard. The only disadvantage could be that ob-
servers are not able to detect subtle abnormalities on NCCT
scans which potentially could be detected by density measure-
ments or machine learning techniques. Therefore, we aimed at a
comparison with readers as the current context of automated
image analysis is the support and potential replacement of a
reader in order to increase the robustness of evaluation.
Independent of the approach, we found other studies
reporting a similar performance. When we compare the
performance of Frontiers ASPECTS with Brainomix e-
ASPECTS, similar sensitivity (54% vs 44–46%) and
Table 2 Performance of Frontier ASPECTS in the test set in comparison to reference standard with optimal thresholds defined in the training set
ASPECTS region Threshold value (%) Specificity (%) Sensitivity (%) TP TN FP FN AUC (95% CI)
CN, IC, INS, LN 5.6 89 57 353 711 87 269 0.795 (0.771–0.819)
M1–M6 4.7 89 41 154 1565 191 220 0.750 (0.722–0.778)
Combined 89 51 507 2276 278 489
All 10 regions 4.9 89 54 533 2274 280 463 0.713 (0.692–0.733)
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specificity (89% vs 91–94%) was found [3, 22]. In addi-
tion, the performance of automated ASPECTS was better
than observers [3, 22]. A similar study analyzing relative
Hounsfield unit density per region found a sensitivity of
45% and a specificity of 93% for a HU ratio threshold of
< 0.94 and an area under the curve of 0.780 [24]. A study
assessing RAPID@IschemaView automated ASPECTS
found a performance equal to the agreement read of ex-
pert neuroradiologists [25].
Finally, a machine learning algorithm with DWI-
ASPECTS as reference standard resulted in ICC of 0.76, a
sensitivity of 66%, and a specificity of 92%. This study, sim-
ilar to the current study, optimized the algorithm on a training
set and tested the performance on a test set [20].
The strength of this study includes the heterogeneity of the
included patients and the use of 18 different scanner types
from four major CT-scanner vendors which enables a reliable
translation of the study results into clinical practice. Second,
the rigorous methodology with subdivision in training and test
set and the multiple metrics to assess the accuracy is a
strength. Third, most studies assessing ASPECTS software
performance with baseline ASPECTS as reference standard
use the ASPECTS assessed by observers for both consensus
for the reference standard as for individual observer analysis,
which created a bias in the analysis of observer agreement [9,
10, 12]. To prevent this bias in our analyses, we strictly split
the expert readers panel, using independent expert readers for
the reference standard consensus and for individual observer
analysis.
A possible limitation of this study is the use of vendor-
specific software, since the software could work better for
CT-scans acquired on Siemens equipment. However, the dis-
criminating performance of the software in ASPECTS regions
did not differ significantly between CT-scans acquired on
Siemens CT-scanners and CT-scanners of other vendors.
Secondly, in our study, we used a panel of observers to pro-
vide ASPECTS, representing the variability in observers for
ASPECTS in clinical practice. Most studies do not describe
the use of a panel of observers to provide ASPECTS, nor does
any author describe the type of ICC they use. A practical
limitation is the use of a fixed specificity of ≥ 90% in the
analyses. The shape of the receiver-operating characteristic
curves in this study suggests a better discriminative ability
between affected and unaffected ASPECTS regions for a low-
er specificity, and one could want to use another threshold
values resulting in a change in specificity or sensitivity, de-
pending on their context and the type of data.
This software tool should not be intended as replacement of
the physician.We would recommend seeing this software tool
in clinical practice as an aid for physicians. Further research is
needed to compare the performance of this ASPECTS soft-
ware to software of other vendors. Besides this, the role of this
ASPECTS software in clinical practice needs to be establishedTa
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by evaluating the added value in predicting outcome com-
pared with ASPECTS based on readers.
Conclusion
In conclusion, the performance of Frontier ASPECTS is com-
parable to expert readers and is able to support readers in the
detection of early ischemic changes in a standardized way.
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